Glutamine metabolism affects the tumor stroma, and it has been reported that the glutamine-metabolizing enzyme GLS1 promotes cancer growth via autophagy in the tumor stroma [48], and it is possible that the effect of WEE1 inhibitors on glutamine metabolism is involved in the suppression of the stromal reaction. The gene discussed is GLS; the disease is neoplasm.